This study revealed the role of lncRNA CASC2 on the inflammation and apoptosis of HFLSs in RA, the mechanisms underlying these phenomena; the novel regulatory signaling axis, miR-18a-5p/BTG3, may represent a potential target for RA treatment. The gene discussed is BTG3; the disease is rheumatoid arthritis.